NCT02661438 is a NA clinical trial of Placebo to Ciprofloxacin DPI (BAYQ3939) in Bronchiectasis, sponsored by Bayer.

Who is sponsoring NCT02661438?

NCT02661438 is sponsored by Bayer.

What drugs are being tested in NCT02661438?

Interventions in NCT02661438: Placebo to Ciprofloxacin DPI (BAYQ3939).

What condition does NCT02661438 study?

NCT02661438 studies Bronchiectasis, Pulmonary Disease, Chronic Obstructive.

Is NCT02661438 still recruiting?

NCT02661438 is currently completed. Last updated 19 December 2018.

Last reviewed 2018-12-19 · How we verify

NCT02661438

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Summative Usability Study of Ciprofloxacin Dry Powder for Inhalation Using Placebo

Completed NA Last updated 19 December 2018

What this trial tests

NA trial testing Placebo to Ciprofloxacin DPI (BAYQ3939) in Bronchiectasis in 46 participants. Completed in 17 March 2016.

Timeline

12 January 2016

Primary endpoint
17 March 2016

17 March 2016

Quick facts

Lead sponsor	Bayer
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	other
Enrollment	46
Start date	12 January 2016
Primary completion	17 March 2016
Estimated completion	17 March 2016
Sites	2 locations across United States

Drugs / interventions tested

Placebo to Ciprofloxacin DPI (BAYQ3939) — full drug profile →

Conditions studied

Bronchiectasis — all drugs for Bronchiectasis →
Pulmonary Disease, Chronic Obstructive — all drugs for Pulmonary Disease, Chronic Obstructive →

Sponsor

Bayer — full company profile →

Who can join

40 and older, any sex, with Bronchiectasis or Pulmonary Disease, Chronic Obstructive. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The rationale of this study is to conduct a summative (i.e., validation) usability test of Ciprofloxacin Dry Powder for Inhalation (DPI) and the associated Instructions for Use.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Inhaled RNA Therapeutics for Obstructive Airway Diseases: Recent Advances and Future Prospects.
Xu Y, Thakur A, Zhang Y, Foged C. · · 2021 · cited 24× · PMID 33525500 · DOI 10.3390/pharmaceutics13020177
Continuous versus intermittent antibiotics for bronchiectasis.
Donovan T, Felix LM, Chalmers JD, Milan SJ, et al · · 2018 · cited 8× · PMID 29860722 · DOI 10.1002/14651858.cd012733.pub2

Verify or expand the search:

Other recruiting trials for Bronchiectasis

Currently open trials in the same condition.

NCT07283497 — Itraconazole Therapy In Bronchiectasis With Airway Mold · Phase 4 · recruiting
NCT07188675 — Functional Inspiratory Training in Bronchiectasis · NA · recruiting
NCT06897761 — Development of an Interactive Digital Respiratory Game and Device and Investigation of Its Effectiveness in Children Wit · NA · recruiting
NCT07147803 — Sleep Quality in Patients With Non-cystic Fibrosis Bronchiectasis · active not recruiting
NCT07274631 — A Cohort for Inflammatory Respiratory Diseases: From Phenotyping to Personalised Medicine · recruiting

Other Bayer trials

Trials by the same sponsor.

NCT05900388 — A Study to Observe the Pattern of Use and Safety of Rivaroxaban in Children Under 2 Years Old With Venous Thromboembolis · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT05477953 — An Observational Pregnancy Safety Study in Women Who Were Exposed to the Drug Nifurtimox During Pregnancy to Learn About · not yet recruiting
NCT07192952 — A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Child · Phase 3 · not yet recruiting
NCT07450599 — A Study to Learn How Well a Combination of Darolutamide and Androgen Deprivation Therapy (ADT) Works as a Treatment Befo · Phase 2 · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02661438 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Bayer
Last refreshed: 19 December 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02661438.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing